Naloxone Hydrochloride | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Naloxone Hydrochloride
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Naloxone Hydrochloride

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Contact Supplier

xyz-pharma-m-2025-06-09

Naloxone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 12 CEP/COS, 1 JDMF, 3 EU WC, 3 KDMF, 18 NDC API, 18 Listed Suppliers, $ API Reference Price

40 API Suppliers
13 USDMF
12 CEP/COS
1 JDMF
3 EU WC
3 KDMF
18 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

72 Drugs in Development

72 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

345 FDF Dossiers, 164 FDA Orange Book, 83 Europe, 20 Canada, 34 Australia, 11 South Africa, 33 Listed Dossiers

345 FDF Dossiers
164 FDA Orange Book
83 Europe
20 Canada
34 Australia
11 South Africa
33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 3 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 31 Direct Compression, 26 Taste Masking, 24 Controlled & Modified Release, 23 Granulation, 23 Thickeners and Stabilizers, 22 Co-Processed Excipients, 22 Disintegrants & Superdisintegrants, 18 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 9 Solubilizers, 9 Topical, 9 Parenteral, 6 Film Formers & Plasticizers, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

79 Fillers, Diluents & Binders
43 Coating Systems & Additives
31 Direct Compression
26 Taste Masking
24 Controlled & Modified Release
23 Granulation
23 Thickeners and Stabilizers
22 Co-Processed Excipients
22 Disintegrants & Superdisintegrants
18 Chewable & Orodispersible Aids
18 Lubricants & Glidants
9 Solubilizers
9 Topical
9 Parenteral
6 Film Formers & Plasticizers
5 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Emulsifying Agents
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

245 News #PharmaBuzz

245 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 76 Regulatory FDF Prices

2 US Medicaid Prescriptions
76 Regulatory FDF Prices

MARKET PLACE

18 APIs, 10 FDF Dossiers

18 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

155 US Patents, 2 US Exclusivities

155 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

3 EDQM
5 Others

$ API Ref.Price (USD/KG) : 8,779 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

20 All

01 1EMERGENT OPERATIONS IRELAND LIMITED

02 2HIKMA CANADA LIMITED

03 4Indivior

04 3OMEGA LABORATORIES LIMITED

05 1Octapharma

06 4PURDUE PHARMA

07 3SANDOZ CANADA INCORPORATED

08 1STERINOVA INC.

09 1TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

20 All

01 11NALOXONE HYDROCHLORIDE

02 4NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE)

03 1Naloxone

04 4Naloxone Hydrochloride

filter Dosage Form Reset all filters

20 All

01 4FILM, SOLUBLE

02 1KIT

03 2LIQUID

04 7SOLUTION

05 2SPRAY, METERED DOSE

06 4TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

20 All

01 1INJECTABLE NALOXONE HYDROCHLORIDE

02 1NALOXONE HCL INJECTION - 0.4MG/ML USP

03 1NALOXONE HCL INJECTION - 1MG/ML USP

04 2NALOXONE HYDROCHLORIDE INJECTION

05 2NALOXONE HYDROCHLORIDE INJECTION USP

06 1NALOXONE INJECTABLE

07 1NARCAN NASAL SPRAY

08 1OCTAPLEX

09 1S.O.S. NALOXONE HYDROCHLORIDE INJECTION

10 4SUBOXONE

11 4TARGIN

12 1TEVA-NALOXONE NASAL SPRAY

Veranova Naloxone hydrochloride

List of Suppliers

Product Main Page

01

EMERGENT OPERATIONS IRELAND LIMITED

Simposio AFI

Not Confirmed

EMERGENT OPERATIONS IRELAND LIMITED

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Ethical

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NARCAN NASAL SPRAY

Dosage Form : SPRAY, METERED DOSE

Dosage Strength : 4MG/0.1ML

Packaging :

Approval Date :

Application Number : 2458187

Regulatory Info : Ethical

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

02

HIKMA CANADA LIMITED

Simposio AFI

Not Confirmed

HIKMA CANADA LIMITED

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : NALOXONE HYDROCHLORIDE INJECTION USP

Dosage Form : SOLUTION

Dosage Strength : 0.4MG/ML

Packaging : 10X1ML

Approval Date :

Application Number : 2382482

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

HIKMA CANADA LIMITED

Simposio AFI

Not Confirmed

HIKMA CANADA LIMITED

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Ethical

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE INJECTABLE

Dosage Form : SOLUTION

Dosage Strength : 0.4MG/ML

Packaging :

Approval Date :

Application Number : 2458578

Regulatory Info : Ethical

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Octapharma

Simposio AFI

Not Confirmed

Octapharma

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule D

Registration Country : Canada

Brand Name : OCTAPLEX

Dosage Form : KIT

Dosage Strength : 620UNIT/VIAL

Packaging : 20ML

Approval Date :

Application Number : 2294664

Regulatory Info : Schedule D

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

PURDUE PHARMA

Simposio AFI

Not Confirmed

PURDUE PHARMA

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 2.5MG

Packaging : 10/14/20/28/30/50/56/60/98/100/250

Approval Date :

Application Number : 2387425

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

PURDUE PHARMA

Simposio AFI

Not Confirmed

PURDUE PHARMA

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 5MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339609

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

PURDUE PHARMA

Simposio AFI

Not Confirmed

PURDUE PHARMA

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 10MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339617

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

PURDUE PHARMA

Simposio AFI

Not Confirmed

PURDUE PHARMA

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 20MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339625

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SANDOZ CANADA INCORPORATED

Simposio AFI

Not Confirmed

SANDOZ CANADA INCORPORATED

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE HCL INJECTION - 1MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 1MG/ML

Packaging : 2ML

Approval Date :

Application Number : 2148714

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

10

SANDOZ CANADA INCORPORATED

Simposio AFI

Not Confirmed

SANDOZ CANADA INCORPORATED

Simposio AFI

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE HCL INJECTION - 0.4MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 0.4MG/ML

Packaging : 1/10ML

Approval Date :

Application Number : 2148706

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!